A placebo effect is a change associated with expectations and the context of treatment. It can influence symptoms, particularly how people experience pain. It does not mean an inactive treatment reliably reverses an underlying disease.
Symptoms and disease are different outcomes
In a randomized crossover asthma study, participants reported improvement with both active albuterol and placebo interventions. But the active drug improved measured lung function more than the inactive interventions. The placebo inhaler did not outperform no intervention on that objective measure. Feeling better and having better airflow were different outcomes in this study. Read the original research.
A subjective response is real to the person experiencing it, but cannot establish that a treatment corrected the cause. Findings must be interpreted for the particular condition and measurement.
Why context can influence symptoms
Expectations, previous experiences, learning, and interactions with clinicians can shape responses to treatment. Researchers investigate these mechanisms and how they differ across individuals. They do not imply that symptoms are imaginary or a person's fault.
What a placebo group does and does not show
Improvement in a placebo group is not all attributable to the placebo effect. Symptoms can fluctuate naturally. People may join a trial when symptoms are unusually severe and subsequently improve. Reporting and measurement can also influence the result. Comparisons with no-treatment groups can help separate some of these effects.
Do open-label placebos work?
Some studies investigate placebos given openly, with participants knowing they contain no active drug. NCCIH describes research suggesting benefits in some circumstances. That does not establish universal efficacy, durable benefit across conditions, or a replacement for effective treatment.
How to evaluate a claim
Look at the outcome being measured, the comparison group, the number of participants, and the follow-up period. A change in a symptom questionnaire is different from a change in a lab test or a reduction in serious complications. A small study can be useful without settling the question.
Treatment context matters, and symptom relief deserves attention. But evidence should distinguish symptoms from objective disease outcomes and describe uncertainty. Do not stop prescribed treatment based on a general discussion of placebos; discuss treatment questions with your clinician.
Correction, October 15, 2026: the previous version incorrectly implied that a placebo asthma inhaler produces meaningful bronchodilation. The study discussed here distinguishes subjective improvement from measured lung function.